// App-Quantinova.ai

6523 : Food and Drug Administration analysis of 1332 single patient and emergency use expanded access (compassionate use) requests for patients with cancer over a duration of three years (2012-2014).

Researchers

Presenter

  • Steven J. Lemery

Principal Investigators

  • Sham Mailankody

  • Dickran Kazandjian

  • Marie-Anne Damiette Smit

  • Gideon Michael Blumenthal

  • Tamy Kim

  • Patricia Keegan

  • Richard Pazdur

Medical Centers

  • U.S. Food and Drug Administration, Silver Spring, MD

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • U.S. Food and Drug Administration, Silver Spring, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved